Search for a command to run...
Natural Capsules Ltd. shows moderate growth and profitability metrics compared to its peers in the Pharmaceuticals & Drugs industry. While it has strong ROE and lower debt levels, its valuation ratios suggest it may be overvalued relative to growth. Companies like Cipla and Dr. Reddy's demonstrate superior profitability metrics, indicating a more favorable investment outlook.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
NATCAPSUQ | ₹197.00 | ₹203.72Cr | 30.36 | 2.87% | 0.45 |
SUNPHARMA | ₹1,563.35 | ₹3,75,099.26Cr | 87.59 | 17.60% | 0.04 |
DIVISLAB | ₹6,091.05 | ₹1,61,698.50Cr | 73.20 | 16.46% | - |
CIPLA | ₹1,587.60 | ₹1,28,217.27Cr | 23.73 | 22.77% | 0.01 |
TORNTPHARM | ₹3,581.55 | ₹1,21,215.77Cr | 61.53 | 24.28% | 0.57 |
DRREDDY | ₹1,280.30 | ₹1,06,835.27Cr | 15.50 | 26.86% | 0.07 |
MANKIND | ₹2,518.95 | ₹1,03,926.59Cr | 55.18 | 28.38% | 0.02 |